Endocrine Abstracts

Introduction: Sestamibi (SM) and ultrasound (US) are routinely used for preoperative localisation of abnormal parathyroids in patients with hyperparathyroidism. Minimally invasive parathyroidectomy (MIP) is recommended if localisation is concordant, otherwise neck exploration is the method of choice.Aim: To assess whether introduction of intraoperative parathormone (IOPTH) monitoring allows us to perform MIP successfully in patients with non concordant f...